Research News and Research

RSS
Group Health gets $2 million to study value-based insurance

Group Health gets $2 million to study value-based insurance

ESHRE workshop highlights problems related to MAR treatment in Europe

ESHRE workshop highlights problems related to MAR treatment in Europe

Team-based health care adds tremendous value to patient experience

Team-based health care adds tremendous value to patient experience

Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID

Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID

Orthovita's Cortoss Bone Augmentation study results to be presented at NASS Annual Meeting

Orthovita's Cortoss Bone Augmentation study results to be presented at NASS Annual Meeting

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

PDGF identified as key factor in proliferation and transformation of epicardial cells

PDGF identified as key factor in proliferation and transformation of epicardial cells

Survey of active, retired military officials highlights attitudes about foreign aid

Survey of active, retired military officials highlights attitudes about foreign aid

AOA launches 'Break Through Your Pain' public education campaign

AOA launches 'Break Through Your Pain' public education campaign

Lumosity.com launches Italian version of cognitive training service

Lumosity.com launches Italian version of cognitive training service

WHO Eastern Mediterranean meeting opens in Cairo

WHO Eastern Mediterranean meeting opens in Cairo

MRF explores ways to accelerate medical research with online gaming technology

MRF explores ways to accelerate medical research with online gaming technology

Synergetics anticipates $13 million net sales for fourth quarter 2010

Synergetics anticipates $13 million net sales for fourth quarter 2010

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

First Edition: October 6, 2010

First Edition: October 6, 2010

U.N. calls for increased efforts to reduce urban poverty, improve city living conditions

U.N. calls for increased efforts to reduce urban poverty, improve city living conditions

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Androgen deprivation therapy for prostate cancer associated with structural bone decay

Androgen deprivation therapy for prostate cancer associated with structural bone decay

Ibuprofen provides pain relief within two hours in 49% of migraine sufferers

Ibuprofen provides pain relief within two hours in 49% of migraine sufferers

Elsevier launches new publishing model to enhance publication process

Elsevier launches new publishing model to enhance publication process

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.